Case Reports
doi: 10.1016/S0140-6736(05)77774-6.
Abnormal fat distribution and use of protease inhibitors
- PMID: 9734915
- DOI: 10.1016/S0140-6736(05)77774-6
Item in Clipboard
Case Reports
Abnormal fat distribution and use of protease inhibitors
Lancet.
.
No abstract available
Comment on
-
"Buffalo hump" in men with HIV-1 infection.Lancet. 1998 Mar 21;351(9106):867-70. doi: 10.1016/S0140-6736(97)11443-X. Lancet. 1998. PMID: 9525364
-
Visceral abdominal-fat accumulation associated with use of indinavir.Lancet. 1998 Mar 21;351(9106):871-5. doi: 10.1016/S0140-6736(97)11518-5. Lancet. 1998. PMID: 9525365
Similar articles
-
Abnormal fat distribution and use of protease inhibitors.Lancet. 1998 Jun 6;351(9117):1736-7. doi: 10.1016/s0140-6736(05)77776-x. Lancet. 1998. PMID: 9734917 No abstract available.
-
Abnormal fat distribution and use of protease inhibitors.Lancet. 1998 Jun 6;351(9117):1736. doi: 10.1016/S0140-6736(05)77775-8. Lancet. 1998. PMID: 9734916 No abstract available.
-
Visceral abdominal-fat accumulation associated with use of indinavir.Lancet. 1998 Mar 21;351(9106):871-5. doi: 10.1016/S0140-6736(97)11518-5. Lancet. 1998. PMID: 9525365
-
HAART-associated body habitus and metabolic changes, Part 1.AIDS Read. 2000 Nov;10(11):622, 629-31. AIDS Read. 2000. PMID: 11186180 Review. No abstract available.
-
Metabolic effects of protease inhibitor therapy.AIDS Read. 1999 Jul;9(4):254-6, 259-60, 266-9. AIDS Read. 1999. PMID: 12737115 Review.
Cited by
-
Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?Drug Saf. 2000 Jul;23(1):57-76. doi: 10.2165/00002018-200023010-00004. Drug Saf. 2000. PMID: 10915032 Review.
-
Metabolic complications associated with HIV protease inhibitor therapy.Drugs. 2003;63(23):2555-74. doi: 10.2165/00003495-200363230-00001. Drugs. 2003. PMID: 14636077 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
